Search results
Jul 2, 2024 · About CYFENDUS ® (Anthrax Vaccine Adsorbed, Adjuvanted) Indication. CYFENDUS ® (Anthrax Vaccine Adsorbed, Adjuvanted) is a vaccine indicated for post-exposure prophylaxis of anthrax disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when given with recommended antibacterial drugs.
Jul 1, 2024 · Anthrax is a rare condition which is caused by a spore-forming bacterium. Two people have tested positive for anthrax in Odisha’s Koraput district. The symptoms of anthrax depend on the type of the illness. Read on to know the condition, its symptoms, risk factors and complications of the rare and serious condition. , Health News - Times Now
3 days ago · Epstein–Barr virus infectious mononucleosis (Mono) Fever – usually lasting 14 days; often mild. Sore throat – usually severe for 3–5 days, before resolving in the next 7–10 days. Swollen glands – mobile; usually located around the back of the neck (posterior cervical lymph nodes) and sometimes throughout the body.
Jun 19, 2024 · Anthrax, a zoonotic disease that can spread from animals to humans, was a significant public health concern during the war. The lack of vaccinations, coupled with the ongoing humanitarian crisis ...
Jul 2, 2024 · Anthrax outbreak in Odisha: Key facts about the disease. Times Now Digital. Updated Jul 2, 2024, 13:45 IST. In a quiet village nestled in Koraput district, Odisha, recent events have brought concern to its residents.Two villagers tested positive for anthrax after consuming meat from a diseased cattle at a feast.
- 2 min
Jun 26, 2024 · गांव जमौली में इन दिनो गलोघोटू रोग फैलता जा रहा है। पशुपालन विभाग की वैक्सीन लगाने के बाद एक भैंस मर गई। जब कि अभी 50 भैसें बीमार चल रही है। दुधारू मवेशियो में गलोघोटू का रोग फैलने से ...
Jun 21, 2024 · Telavancin, a semisynthetic lipoglycopeptide antibiotic, was evaluated in this study as a novel therapeutic against anthrax disease. The low minimum inhibitory concentration against all strains tested and rapid bactericidal in vivo activity demonstrate that telavancin has the potential to be an effective alternative for the treatment or prophylaxis of anthrax infection.
